Stacey Kalovidouris is the Executive Director of Rice University’s Institute of Biosciences and Bioengineering (IBB). In this role, she facilitates cross-disciplinary research and education, fosters ties with the Texas Medical Center, creates partnerships with industry, and promotes the translation of research.
Stacey brings 17 years of experience working at the forefront of early-stage scientific advances and discoveries. She would like to leverage her deep domain expertise and explore the world of innovation investing.
Stacey is an inventor on a patent for a carbohydrate-protein method of inducing neuronal growth and has published research papers in the diverse areas of nanotechnology, glycobiology, immunology, neuroscience, and drug delivery of cancer therapeutics.
Prior to becoming IBB’s Executive Director, Stacey was a Senior Scientist for Calando Pharmaceuticals, a biopharmaceutical company providing targeted therapeutics for the development of nanoparticle drug formulations.
Education, Personal, and Fellowship
Stacey completed her post-doctoral training at the California Institute of Technology and holds a PhD in chemistry from the University of California at Los Angeles. She received her BA degree in biochemistry from Swarthmore College.
As a member of Class 19, Stacey served her fellowship at Rice University under the mentorship of David Schubert of Rice’s Houston Area Translational Research Consortium.